Cannabo will Research Cannabinoid Treatments with Terra

- May 15th, 2017

Canabo Medical entered a collaborative agreement with Terra Life Sciences to work on cannabinoid-based treatments.

Canabo Medical (TSXV:CMM, OTCQB:CAMDF) entered a collaborative agreement with Terra Life Sciences to work on cannabinoid-based treatments.

As quoted in the press release:
The intended outcome of the agreement will be to develop new cannabinoid-based formulations to target specific medical conditions and illnesses such as chronic pain or anxiety. In addition, the agreement specifies both parties will conduct joint medical research and testing, and share future revenues from any new medical formulations and IP developed.
Key aspects of the Agreement include both companies working jointly to identify, develop and conduct medical research on new cannabinoid formulations designed to assist patients with specific conditions such as pain management and anxiety. The Agreement also provides for revenue sharing on any licensing revenues resulting from any newly developed products.

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

Leave a Reply

Your email address will not be published. Required fields are marked *